Perspective Therapeutics Inc (CATX)
3.47
+0.47
(+15.67%)
USD |
NYAM |
Nov 22, 16:00
3.49
+0.02
(+0.58%)
Pre-Market: 20:00
Perspective Therapeutics Free Cash Flow: -40.58M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
September 30, 2024 | -40.58M |
June 30, 2024 | -24.58M |
March 31, 2024 | -23.28M |
December 31, 2023 | -37.98M |
September 30, 2023 | -30.74M |
June 30, 2023 | -23.40M |
March 31, 2023 | -16.22M |
September 30, 2022 | -7.691M |
June 30, 2022 | -7.976M |
March 31, 2022 | -6.213M |
December 31, 2021 | -5.479M |
September 30, 2021 | -4.905M |
June 30, 2021 | -3.218M |
March 31, 2021 | -2.858M |
December 31, 2020 | -3.05M |
September 30, 2020 | -3.614M |
June 30, 2020 | -3.914M |
March 31, 2020 | -4.117M |
December 31, 2019 | -4.677M |
September 30, 2019 | -4.518M |
June 30, 2019 | -5.493M |
March 31, 2019 | -5.971M |
December 31, 2018 | -5.666M |
September 30, 2018 | -6.06M |
June 30, 2018 | -6.049M |
Date | Value |
---|---|
March 31, 2018 | -5.964M |
December 31, 2017 | -6.342M |
September 30, 2017 | -6.476M |
June 30, 2017 | -6.261M |
March 31, 2017 | -6.219M |
December 31, 2016 | -5.661M |
September 30, 2016 | -4.75M |
June 30, 2016 | -4.363M |
March 31, 2016 | -3.607M |
December 31, 2015 | -3.801M |
September 30, 2015 | -3.615M |
June 30, 2015 | -3.655M |
March 31, 2015 | -3.989M |
December 31, 2014 | -3.320M |
September 30, 2014 | -3.521M |
June 30, 2014 | -3.265M |
March 31, 2014 | -3.047M |
December 31, 2013 | -3.296M |
September 30, 2013 | -3.020M |
June 30, 2013 | -3.069M |
March 31, 2013 | -2.933M |
December 31, 2012 | -3.028M |
September 30, 2012 | -2.931M |
June 30, 2012 | -2.543M |
March 31, 2012 | -2.556M |
Free Cash Flow Range, Past 5 Years
-40.58M
Minimum
Sep 2024
-2.858M
Maximum
Mar 2021
-13.39M
Average
-6.213M
Median
Mar 2022
Free Cash Flow Benchmarks
Plus Therapeutics Inc | -11.95M |
Retractable Technologies Inc | -9.854M |
InfuSystems Holdings Inc | 2.464M |
Xtant Medical Holdings Inc | -17.28M |
Catheter Precision Inc | -8.381M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | 3.366M |
Cash from Investing (Quarterly) | -29.74M |
Cash from Financing (Quarterly) | 0.628M |
Free Cash Flow Per Share (Quarterly) | -0.373 |
Free Cash Flow Yield | -21.77% |